CN109288042A - A kind of method and application using probiotics fermention kelp preparation malignant tumour medical food raw material - Google Patents
A kind of method and application using probiotics fermention kelp preparation malignant tumour medical food raw material Download PDFInfo
- Publication number
- CN109288042A CN109288042A CN201811103176.4A CN201811103176A CN109288042A CN 109288042 A CN109288042 A CN 109288042A CN 201811103176 A CN201811103176 A CN 201811103176A CN 109288042 A CN109288042 A CN 109288042A
- Authority
- CN
- China
- Prior art keywords
- kelp
- bacillus
- fermentation
- powder
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 42
- 235000013305 food Nutrition 0.000 title claims abstract description 28
- 201000011510 cancer Diseases 0.000 title claims abstract description 21
- 239000002994 raw material Substances 0.000 title claims abstract description 19
- 239000006041 probiotic Substances 0.000 title claims abstract description 13
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 13
- 229940001881 kelp preparation Drugs 0.000 title claims abstract description 4
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 95
- 238000000855 fermentation Methods 0.000 claims abstract description 77
- 230000004151 fermentation Effects 0.000 claims abstract description 77
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 60
- 239000007788 liquid Substances 0.000 claims abstract description 54
- 239000000843 powder Substances 0.000 claims abstract description 43
- 241000894006 Bacteria Species 0.000 claims abstract description 39
- 239000004310 lactic acid Substances 0.000 claims abstract description 30
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 30
- 239000006228 supernatant Substances 0.000 claims abstract description 18
- 238000001035 drying Methods 0.000 claims abstract description 17
- 230000001376 precipitating effect Effects 0.000 claims abstract description 17
- 239000001963 growth medium Substances 0.000 claims abstract description 12
- 238000000926 separation method Methods 0.000 claims abstract description 12
- 239000000470 constituent Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 18
- 230000001954 sterilising effect Effects 0.000 claims description 17
- 241001037822 Bacillus bacterium Species 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 7
- 238000001694 spray drying Methods 0.000 claims description 7
- 241000194103 Bacillus pumilus Species 0.000 claims description 6
- 241000186660 Lactobacillus Species 0.000 claims description 6
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 6
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 229940039696 lactobacillus Drugs 0.000 claims description 6
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 6
- 241000193749 Bacillus coagulans Species 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000001888 Peptone Substances 0.000 claims description 5
- 108010080698 Peptones Proteins 0.000 claims description 5
- 229940054340 bacillus coagulans Drugs 0.000 claims description 5
- 235000015278 beef Nutrition 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 239000012092 media component Substances 0.000 claims description 5
- 235000019319 peptone Nutrition 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 241000194108 Bacillus licheniformis Species 0.000 claims description 4
- 244000063299 Bacillus subtilis Species 0.000 claims description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 4
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 4
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 4
- 230000032683 aging Effects 0.000 claims description 4
- 238000010612 desalination reaction Methods 0.000 claims description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 3
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 claims description 2
- 235000013402 health food Nutrition 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 229940066779 peptones Drugs 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 235000013406 prebiotics Nutrition 0.000 abstract description 2
- 239000002244 precipitate Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 24
- 239000000047 product Substances 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 150000008442 polyphenolic compounds Chemical class 0.000 description 12
- 235000013824 polyphenols Nutrition 0.000 description 12
- 238000011160 research Methods 0.000 description 11
- 230000000259 anti-tumor effect Effects 0.000 description 9
- 241001474374 Blennius Species 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 238000012549 training Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
- 229920001543 Laminarin Polymers 0.000 description 2
- 241000199919 Phaeophyceae Species 0.000 description 2
- 241000015177 Saccharina japonica Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000004900 autophagic degradation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000007365 immunoregulation Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
- MXNRLFUSFKVQSK-UHFFFAOYSA-N 2-Amino-6-(trimethylazaniumyl)hexanoate Chemical compound C[N+](C)(C)CCCCC(N)C([O-])=O MXNRLFUSFKVQSK-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000005717 Laminarin Substances 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102000009664 Microtubule-Associated Proteins Human genes 0.000 description 1
- 108010020004 Microtubule-Associated Proteins Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000593522 Sargassum thunbergii Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- -1 iodine, alginic acid Chemical class 0.000 description 1
- DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000005170 neoplastic cell Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001875 tumorinhibitory effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/65—Addition of, or treatment with, microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pediatric Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a kind of methods and application using probiotics fermention kelp preparation malignant tumour medical food raw material.This method comprises: (1) crushes kelp, Kelp Powder is made；(2) one time fermentation culture medium is added in Kelp Powder, through one time fermentation, kelp first time fermentation liquid is made；(3) second of fermentation liquid of kelp is made in the Mixed Microbes of inoculating lactic acid bacterium or lactic acid bacteria and Bifidobacterium into kelp first time fermentation liquid, secondary fermentation；(4) by second of fermentation liquid through being separated by solid-liquid separation, the spray-dried obtained supernatant dry powder of supernatant, precipitate through low temperature drying, after crushing, be made precipitating dry powder, mixing supernatant dry powder and precipitating dry powder to get.The mode that first passage of the present invention carries out prebiotic microzyme secondary fermentation to kelp prepares malignant tumour medical food raw material, and this method can discharge nutriment and active constituent in kelp.
Description
Technical field
The present invention relates to it is a kind of using probiotics fermention kelp preparation malignant tumour medical food raw material method and application,
In particular to a kind of high activity, suitable for malignant tumour medical food raw material using probiotics fermention extract kelp nutrition and
The method of anti-tumor active ingredient belongs to functional food and technical field of plant extraction.
Background technique
Seaweed species are various, resourceful, are important marine resources.In China, seaweed is mainly based on kelp.Kelp
Also known as thallus laminariae, synthetic fibre cloth, frequently as food and Chinese medicine material, Compendium of Material Medica, " legendary god of farming's book on Chinese herbal medicine position ", " edible book on Chinese herbal medicine " and " in
State's Chinese herbal medicine compilation " in it is on the books.Kelp not only proteins,vitamins,and minerals rich in, also containing such as brown alga
Acid, fucoidin, laminaran, brown alga fiber, mannitol, laminine, high unsaturated lipid boat acid, fucoxanthine and sterols
The physiological activator abundant such as compound.Wherein, fucoidin is reported with immunoregulation effect, antitumor action, resists
Virus function, antibacterial and anti-inflammation functions, antioxidation, the effect of anticoagulant rouge, hypoglycemic effect etc., wherein because fucoidin only accounts for
4% content prevents from growth of cancer cells, and causes apoptosis of tumor cells and cause people's extensive concern.Studies have shown that brown
Algae carbohydrate gum inhibits liver cancer cells QGY7703 to enter logarithmic growth phase, to contain the growth of tumour, fucoidin pair
The tumour inhibiting rate of Hepes can be more than 50%, and not influence the normal growth of mouse, to show the superiority than positive drug.
Seeweed polyphenol is the different compound of a big class formation, has multiple biological activities, at present to seeweed polyphenol anti-tumor activity, anti-
Bacterium antiviral activity, antioxidant activity research are more.Wherein, in sargassum thunbergii brown algae polyphenols to Human Hepatic Carcinoma Cell Line BEL-7402 and
Human lung cancer cell lines A-549 has stronger antitumor action, and optimal inhibition concentration is in 0.085~0.10mgm L/L or so；
Small mucous membrane algae crude extract has selecting cell cytotoxic activity to KB cancer cell, HT-29 cancer cell, to normal cell NIH-3T3 base
Do not have toxicity in sheet.
However, the exploitation of China kelp at present focuses primarily upon kelp food, seaweed (band) fertilizer and iodine, alginic acid, sweet
The extraction for revealing the industrial chemicals such as alcohol, belongs to the shallow processing of seaweed, with low content of technology, added value of product is low, still not to seaweed
Carry out deep processing, the active material in high-efficiency comprehensive utilization seaweed.The research range to seaweed thus must be constantly expanded, greatly
Power reinforces research of seaweed in terms of edible, medicinal, health care, feed, fertilizer and phycocolloid, so as to more sufficiently comprehensively
Utilize marine algae resource.
Korean patent document KR1020140057838A (application number KR1020120124100) discloses a kind of using kelp
The tunning prepared with other raw materials such as brown rice using mixing lactic acid bacteria fermentation, which, which has, promotes body fat point
Solution promotes the functions such as defecation, helps to prevent the diseases such as colorectal cancer and obesity.
Special medicine purposes formula food (FSMP) is to provide nutrition branch for certain diseases or special health status crowd
The Special food classification held and grown up, in the therapeutic effect and postoperative rehabilitation effect that improve disease, the nutrition for improving patient
Situation, enhancing body itself resistance, the horizontal aspect of holistic health for improving patient have good result.In China, FSMP is produced
Industry is in the starting stage, targetedly studies less, and industrialization level is lower, and market is occupied for a long time by foreign food, in amount
The high situation of few valence.To improve China's special medicine purposes formula food sci-tech innovation ability, doctor is pushed to support health industry new and old
Kinetic energy conversion needs the technology research for carrying out medical food, especially research and development medical food material prepared technology.
Summary of the invention
In view of this, preparing the medical food of malignant tumour using probiotics fermention kelp the purpose of the present invention is to provide a kind of
The method and application of product raw material.The raw-food material that this method is extracted is highly-safe, with strong points, pollution-free, while nutritional ingredient,
Activated species and content are high, and tumor inhibitory effect is good, and stability is strong.
Technical solution of the present invention is as follows:
A method of malignant tumour medical food raw material is prepared using probiotics fermention kelp, comprising the following steps:
(1) kelp is crushed, Kelp Powder is made；
(2) one time fermentation culture medium is added in Kelp Powder made from step (1), is uniformly mixed, then accesses bacillus
After bacterium solution, one time fermentation removes bacillus thallus, and kelp first time fermentation liquid is made；
The bacillus be bacillus subtilis, bacillus pumilus, bacillus licheniformis, in bacillus coagulans
A combination of one or more；
(3) inoculating lactic acid bacterium or lactic acid bacteria and Bifidobacterium into kelp first time fermentation liquid made from step (2)
Second of fermentation liquid of kelp is made in Mixed Microbes, secondary fermentation；
The lactic acid bacteria be lactobacillus plantarum, Lactobacillus casei, streptococcus thermophilus, lactobacillus gasseri, lactobacillus acidophilus and
Curl the combination of one or more of lactobacillus；
(4) by second of fermentation liquid made from step (3) through being separated by solid-liquid separation, the spray-dried obtained supernatant dry powder of supernatant,
Precipitating through low temperature drying, after crushing, be made precipitating dry powder, mixing supernatant dry powder and precipitating dry powder to get.
Preferred according to the present invention, in the step (1), kelp is fresh kelp or the kelp after being soaked, after desalination,
It dries to water content≤5%.
According to the present invention it is further preferred that the desalination is to be rinsed 2~5 times using pure water.
According to the present invention it is further preferred that the process that is soaked is as follows: dry kelp is immersed the pure of 10~20 times of quality
In water purification, be soaked 2~7h under conditions of 20~40 DEG C.
According to the present invention it is further preferred that it is described it is dry use drying mode, 45~90 DEG C of drying temperature.
Preferred according to the present invention, in the step (1), powder particle diameter is 10~1000 μm.
It is preferred according to the present invention, in the step (1), further include the steps that sterilizing after crushing；It is further preferred that going out
Bacterium uses irradiation sterilization, in 1000~2,500 1.5~5h of kilorad irradiation sterilization；It is furthermore preferred that the irradiation sterilization time is 3h.
It is preferred according to the present invention, in the step (2), one time fermentation condition are as follows: in 35~38 DEG C of temperature, revolving speed 180
Ferment 24~48h under conditions of~220rpm.
Preferred according to the present invention, in the step (2), one time fermentation media components are as follows, are weight percentage:
1.5~2.5% glucose, 1.0~2.0% peptones, 0.04~0.06% sodium chloride, 0.04~0.06%
The water of beef extract and surplus.
Preferred according to the present invention, in the step (2), the additional amount of Kelp Powder is the 7 of one time fermentation culture medium quality
~12%.
Preferred according to the present invention, in the step (2), the access amount of the bacillus bacterium solution is one time fermentation training
The 1%~5% of matrix amount is supported, the cell concentration of bacillus bacterium solution is 1.5~7.5 × 1010cfu/mL。
It is preferred according to the present invention, in the step (2), removal bacillus thallus using centrifuge separation, 7000~
8~12min is centrifuged under conditions of 10000rpm.
Above-mentioned seawood meal is degraded with a variety of enzymes that bacillus growth generates, and the viscosity of fermented feed liquid gradually increases
Greatly, in order to not influence subsequent fermentation, it is therefore desirable to be separated by solid-liquid separation.
Preferred according to the present invention, in the step (3), the access amount of the lactic acid bacteria is kelp first time fermented liquid
Long-pending 4~6%, the cell concentration of lactic acid bacteria are 2.5~9.5 × 1010cfu/mL。
Preferred according to the present invention, in the step (3), secondary fermentation is that hair is stood under conditions of 28~33 DEG C of temperature
36~72h of ferment.
It is preferred according to the present invention, in the step (4), it is separated by solid-liquid separation to be centrifuged 10 under the conditions of 7000~10000r/min
~20 minutes.
It is preferred according to the present invention, in the step (4), spray drying condition are as follows: 90 DEG C of inlet temperature, outlet temperature 65
DEG C, spray air pressure 0.1Mpa, dry air amount is adjusted to 0.5m3/L；Low temperature drying temperature is 45~65 DEG C.
It is preferred according to the present invention, further include after-ripening step before solid-liquid separation step in the step (4):
Closed standing under the conditions of second of fermentation liquid of kelp is placed in 8~12 DEG C, 15~30d of after-ripening to get.The work of after-ripening
With to make the active constituent in fermentation liquid tend towards stability by low temperature ageing.
It is preferred according to the present invention, in the step (4), crush to pulverize.
Application of the above-mentioned malignant tumour medical food raw material in preparation malignant tumour health food or drug.
Beneficial effect
1, the mode that first passage of the present invention carries out prebiotic microzyme secondary fermentation to kelp prepares the medical food of malignant tumour
Product raw material, this method can discharge nutriment and active constituent in kelp, and not only safe preparation process is reliable, green high-efficient,
The use of chemical reagent strong acid, highly basic is also effectively prevented, exhaust emission is reduced, fermentation liquid contains dietary fiber, reaches no slag
Discharge meets the strategy and policy of environmentally protective and new and old kinetic energy conversion；
2, through the invention the method preparation malignant tumour medical food raw material, containing it is higher with it is antitumor, anti-
The closely related fucoidin of virus, antibacterial anti-inflammatory, antioxidation, polyphenol, fucose content, and by embodiment preparation
Kelp fermentation liquid all has good inhibiting effect to the growth of neuroglial cytoma；Simultaneously the present invention not only it is complete retain and
The active constituent in kelp is released, the fermentation probiotics can produce glutathione, gamma amino butyric acid, extracellular cellulose
Enzyme, pectase isoreactivity ingredient, increase the type and content of active constituent in tunning, it is medical to further improve tumour
The nutrition and curative effect of food formula raw material.
Detailed description of the invention
Fig. 1 is the histogram of polyphenol recovery rate comparison in embodiment 1 and comparative example 1, comparative example 2；
Fig. 2 is the canonical plotting of polyphenol content testing result in kelp first time fermentation liquid in embodiment 1；
Fig. 3 is the inhibition neuroglial cytoma U87/LC3 Electronic Speculum of malignant tumour medical food raw material prepared by embodiment 2
Photo；
Wherein: after a, application when 0h U87/LC3 cell Electron microscope, after b, application when 4h U87/LC3 cell Electronic Speculum
Structure, after c, application when 8h U87/LC3 cell Electron microscope, after d, application when 12h U87/LC3 cell Electron microscope, e,
After application when 16h U87/LC3 cell Electron microscope；
Specific embodiment
Technical solution of the present invention is further elaborated with embodiment with reference to the accompanying drawings of the specification, but the present invention is protected
It is without being limited thereto to protect range.Unless otherwise specified, all technical and scientific terms used herein has and the affiliated technology of the application
The normally understood identical meanings of the those of ordinary skill in field.
Biological material source
The source of heretofore described lactic acid bacteria does not limit, using the lactic acid bacteria of this field food sources；Implement
Lactobacillus plantarum deposit number CICC 20261, Lactobacillus casei deposit number CICC 20277, acidophilus involved in example and comparative example
Lactobacillus deposit number CICC 22150, streptococcus thermophilus deposit number CICC 20370 are purchased from Chinese industrial microorganism fungus kind guarantor
It hides administrative center (CICC)；Lactobacillus gasseri deposit number JCM11657, lactobacillus deposit number JCM2009 is curled, is purchased from Japan
Organism Depositary (Japan collection of microorganisms)；
Heretofore described bacillus is probiotics, and the present invention does not limit the source of the bacillus, adopts
With the bacillus of this field food sources；Bacillus subtilis involved in embodiment and comparative example is purchased from Chinese industrial
Microbiological Culture Collection administrative center (CICC), deposit number CICC24434；Bacillus pumilus deposit number CGMCC 1.7925,
Bacillus licheniformis deposit number CGMCC 1.15832, bacillus coagulans deposit number CGMCC 1.10832 are purchased from Chinese common
Microbiological Culture Collection administrative center；
Test material used in embodiment is the commercially available material of this field routine, can be bought by commercial channel
It arrives.
Crush the atomizer for using Jiangsu Province Ming Feng Machinery Manufacturing Co., Ltd., ordinary commercial products；
Spray drying device is European Union's board OM-1500/OM-1500A lab spray dryer, and the condition of spray drying is set
Be set to: 90 DEG C of inlet temperature, 65 DEG C of outlet temperature, spray air pressure 0.1Mpa, dry air amount is adjusted to 0.5m3/L；Commonly
Commercial product；
It is dry that Medical Equipment Plant of Co., Ltd GZX-9240MBE digital display air dry oven, low temperature are tested using rich prove to be true after interrogation in Shanghai
The temperature of drying is 45~65 DEG C, is dried to water content lower than 3%；Ordinary commercial products；
It pulverizes and same and development in science and technology Co., Ltd the broken machine of KC-701 plant ultra-micropowder, common city is started using Beijing
Sell product；
Mixing is mixed using the V-type mixing machine of Changzhou Qianjiang drying equipment factory production, ordinary commercial products.
Detection method
Fucoidin: according to (fringe light, laminarin isolate and purify and activity research [D] Shandong University, 2004) in
The method of record is detected；
Fucose: according in GB/5009.168-2016 People's Republic of China (PRC) agricultural industry criteria NY/T2279-2202
Method is detected；
Brown algae polyphenols: according to (Yang Huicheng, kelp (Laminaria japonica Aresch) polyphenol extraction separation and
Its antitumor antibacterial activity research [D] Chinese Marine University, 2008) method recorded in is detected；
Polysaccharide: the phend-sulphuric acid that the measurement according to Thick many candies in the outlet SN/T 4260-2015 plant derived foods is recorded
It is detected；
Inhibiting tumour cells experiment: according to (Yang Huicheng, kelp (Laminaria japonica Aresch) polyphenol mention
Take separation and its antitumor antibacterial activity research [D] Chinese Marine University, 2008) in record method detected；
Embodiment 1
A method of malignant tumour medical food raw material is prepared using probiotics fermention kelp, comprising the following steps:
(1) kelp of water content≤5% is crushed to partial size is 500 μm, and Kelp Powder is made in sterilizing；
The kelp is that fresh kelp is dried under the conditions of temperature 70 C after pure water rinses 3 times, is made；
The step of sterilizing, is as follows: in 1500 kilorad irradiation sterilization 3h；
(2) one time fermentation culture medium is added in Kelp Powder made from step (1), the additional amount of Kelp Powder is one time fermentation training
The 10% of matrix amount is supported, is uniformly mixed, after then accessing bacillus bacterium solution, under conditions of 36 DEG C of temperature, revolving speed 200rpm
One time fermentation 36h is carried out, 10min is centrifuged under conditions of 8500rpm and removes bacillus thallus, kelp is made and ferments for the first time
Liquid；
The bacillus is bacillus pumilus；
The one time fermentation media components are as follows, are weight percentage:
1.5% glucose, 1.0% peptone, 0.04% sodium chloride, 0.04% beef extract and the water of surplus；
The access amount of the bacillus bacterium solution is the 3% of one time fermentation culture medium quality, the bacterium of bacillus bacterium solution
Bulk concentration is 5 × 1010cfu/mL；
(3) inoculating lactic acid bacterium or lactic acid bacteria and Bifidobacterium into kelp first time fermentation liquid made from step (2)
Mixed Microbes, the access amount of the lactic acid bacteria are the 5% of kelp first time fermentating liquid volume, the cell concentration of lactic acid bacteria is 3.0 ×
1010Cfu/mL is left to ferment 36h under conditions of 30 DEG C of temperature, and second of fermentation liquid of kelp is made；
The lactic acid bacteria is lactobacillus plantarum；
(4) by second of fermentation liquid made from step (3) through being centrifuged 15 minutes under the conditions of 8500r/min, supernatant is through spraying
After ultramicro grinding, precipitating dry powder is made, mixing supernatant dry powder and precipitating are dry through low temperature drying in dry obtained supernatant dry powder, precipitating
Powder to get.
The spray drying condition are as follows: 90 DEG C of inlet temperature, 65 DEG C of outlet temperature, spray air pressure 0.1Mpa, dry
Air capacity is adjusted to 0.5m3/L；Low temperature drying temperature is 55 DEG C.
According to the method recorded in (Fan Wenle, comprehensive utilizating research [D] the University Of Science and Technology Of Tianjin of kelp, 2006) to step
Suddenly kelp first time fermentation liquid made from (2) is detected, and the results are shown in Table 1:
Fucoidin content and composition in 1 kelp first time fermentation liquid of table
Embodiment 2
A method of malignant tumour medical food raw material is prepared using probiotics fermention kelp, comprising the following steps:
(1) kelp of water content≤5% is crushed to partial size is 10 μm, and Kelp Powder is made in sterilizing；
The kelp is that the kelp after being soaked is dried under the conditions of temperature 45 C after pure water rinses 5 times, is made；
The process that is soaked is as follows: dry kelp being immersed in the pure water of 20 times of quality, be soaked 7h under conditions of 20 DEG C；
The step of sterilizing, is as follows: in 1000 kilorad irradiation sterilization 5h；
(2) one time fermentation culture medium is added in Kelp Powder made from step (1), the additional amount of Kelp Powder is one time fermentation training
Support matrix amount 7%, be uniformly mixed, then access bacillus bacterium solution after, under conditions of 38 DEG C of temperature, revolving speed 180rpm into
Row one time fermentation 48h is centrifuged 12min under conditions of 7000rpm and removes bacillus thallus, and kelp is made and ferments for the first time
Liquid；
The bacillus is the combination of bacillus pumilus, bacillus coagulans；
The one time fermentation media components are as follows, are weight percentage:
2.5% glucose, 2.0% peptone, 0.06% sodium chloride, 0.06% beef extract and the water of surplus.
The access amount of the bacillus bacterium solution is the 1% of one time fermentation culture medium quality, the bacterium of bacillus bacterium solution
Bulk concentration is 7.5 × 1010cfu/mL。
(3) inoculating lactic acid bacterium or lactic acid bacteria and Bifidobacterium into kelp first time fermentation liquid made from step (2)
Mixed Microbes, the access amount of the lactic acid bacteria are the 4% of kelp first time fermentating liquid volume, the cell concentration of lactic acid bacteria is 4.5 ×
1010Cfu/mL is left to ferment 48h under conditions of 33 DEG C of temperature, and second of fermentation liquid of kelp is made；
The lactic acid bacteria is lactobacillus plantarum, curls the combination in lactobacillus；
(4) by second of fermentation liquid made from step (3) through after-ripening, 10 points are then centrifuged under the conditions of 10000r/min
Clock, the spray-dried obtained supernatant dry powder of supernatant, precipitating is through low temperature drying, after ultramicro grinding, precipitating dry powder is made, mixes supernatant
Dry powder and precipitating dry powder to get.
The spray drying condition are as follows: 90 DEG C of inlet temperature, 65 DEG C of outlet temperature, spray air pressure 0.1Mpa, dry
Air capacity is adjusted to 0.5m3/L；Low temperature drying temperature is 65 DEG C.
Steps are as follows for the after-ripening:
Closed standing under the conditions of second of fermentation liquid of kelp is placed in 8 DEG C, after-ripening 30d to get.The effect of after-ripening is to pass through
Low temperature ageing makes the active constituent in fermentation liquid tend towards stability.
Embodiment 3
A method of malignant tumour medical food raw material is prepared using probiotics fermention kelp, comprising the following steps:
(1) kelp of water content≤5% is crushed to partial size is 1000 μm, and Kelp Powder is made in sterilizing；
The kelp is that the kelp after being soaked is dried under the conditions of 90 DEG C of temperature after pure water rinses 2 times, is made；
The process that is soaked is as follows: dry kelp being immersed in the pure water of 10 times of quality, be soaked 2h under conditions of 40 DEG C；
The step of sterilizing, is as follows: in 2500 kilorad irradiation sterilization 1.5h；
(2) one time fermentation culture medium is added in Kelp Powder made from step (1), the additional amount of Kelp Powder is one time fermentation training
The 12% of matrix amount is supported, is uniformly mixed, after then accessing bacillus bacterium solution, under conditions of 35 DEG C of temperature, revolving speed 220rpm
It carries out one time fermentation for 24 hours, 8min is centrifuged under conditions of 10000rpm and removes bacillus thallus, kelp is made and ferments for the first time
Liquid；
The bacillus be bacillus subtilis, bacillus pumilus, bacillus licheniformis, bacillus coagulans group
It closes；
The one time fermentation media components are as follows, are weight percentage:
2.0% glucose, 1.5% peptone, 0.046% sodium chloride, 0.05% beef extract and the water of surplus.
The access amount of the bacillus bacterium solution is the 5% of one time fermentation culture medium quality, the bacterium of bacillus bacterium solution
Bulk concentration is 1.5 × 1010cfu/mL。
(3) inoculating lactic acid bacterium or lactic acid bacteria and Bifidobacterium into kelp first time fermentation liquid made from step (2)
Mixed Microbes, the access amount of the lactic acid bacteria are the 6% of kelp first time fermentating liquid volume, the cell concentration of lactic acid bacteria is 5.0 ×
1010Cfu/mL is left to ferment 52h under conditions of 28~33 DEG C of temperature, and second of fermentation liquid of kelp is made；
The lactic acid bacteria be lactobacillus plantarum, Lactobacillus casei, streptococcus thermophilus, lactobacillus gasseri, lactobacillus acidophilus and
Curl the combination of lactobacillus；
(4) by second of fermentation liquid made from step (3) through after-ripening, 10 points are then centrifuged under the conditions of 10000r/min
Clock, the spray-dried obtained supernatant dry powder of supernatant, precipitating is through low temperature drying, after ultramicro grinding, precipitating dry powder is made, mixes supernatant
Dry powder and precipitating dry powder to get.
The spray drying condition are as follows: 90 DEG C of inlet temperature, 65 DEG C of outlet temperature, spray air pressure 0.1Mpa, dry
Air capacity is adjusted to 0.5m3/L；Low temperature drying temperature is 65 DEG C.
Steps are as follows for the after-ripening:
Closed standing under the conditions of second of fermentation liquid of kelp is placed in 8 DEG C, after-ripening 30d to get.The effect of after-ripening is to pass through
Low temperature ageing makes the active constituent in fermentation liquid tend towards stability.
Comparative example 1
The method that water proposes, acid refers to enzymolysis and extraction is respectively adopted to extract fucoidin；According to (Fan Wenle, kelp
Comprehensive utilizating research [D] University Of Science and Technology Of Tianjin, 2006) in record method extract.
Comparative example 2
Method as described in Example 2, the difference is that, one time fermentation uses lactobacillus-fermented, and secondary fermentation uses
Bacillus.
Experimental example 1
According to the method recorded in (Fan Wenle, comprehensive utilizating research [D] the University Of Science and Technology Of Tianjin of kelp, 2006) to reality
Apply in example 1 and comparative example 1 it is obtained difference products heteroglycan and fucoidin content detected, the results are shown in Table 1:
Heteroglycan and fucoidin content balance result in 2 embodiment 1 of table and comparative example 1
As can be seen from Table 2, the polysaccharide of embodiment 1 and fucoidin content with the hot water water in comparative example 1 mentions, acid refers to
Enzymolysis and extraction significantly increases, and makees wherein being reported with immunoregulation effect, antitumor action, antivirus action, antibacterial anti-inflammatory
With, antioxidation, anticoagulant rouge effect, hypoglycemic effect fucoidin content be acidolysis extract 1.93 times, be hot water leaching
1.75 times mentioned；
According to the method recorded in (Fan Wenle, comprehensive utilizating research [D] the University Of Science and Technology Of Tianjin of kelp, 2006) to reality
The content of seeweed polyphenol for applying difference products obtained in example 1 and comparative example 1 is detected, as a result as shown in Figure 1；
As seen from Figure 1, the seeweed polyphenol content with clear anti-tumor activity in embodiment 2 is in comparative example 1
Mention 2.36 times of hot water water, extract 2.18 times, 1.65 times of comparative example 2 of acidolysis.By above data as can be seen that different benefits
The enzymatic hydrolysis sequence of raw bacterium also has significant impact to seeweed polyphenol content.
Experimental example 2
LC3 albumen is a kind of microtubule associated protein, and the variation of specificity, surrounding appearance point can occurs in it in cell autophagy
The structure of poly- shape.And the LC3 albumen of neuroglial cytoma U87/LC3 tumor strain is marked by GFP green fluorescence, can pass through fluorescence
Micro- sem observation.
Influence of the product to neuroglial cytoma U87/LC3 in embodiment 3 is examined with the following method, and step is such as
Under:
(1) neuroglial cytoma U87/LC3 plating cells carry out adherent training in the small glass culture dish of 5cm diameter
It supports, the cell liquid in each culture dish keeps 2mL, incubator culture 18h.
(2) 2.5 ‰ (mass ratio) embodiment, 3 fermentation liquid is added, does 5 groups in parallel respectively, wherein one group is not add implementation
4h, 8h, 12h are cultivated in 3 blank control of example, after 16h, carry out observation variation with fluorescence microscope.
As seen from Figure 3, after product made from embodiment 3 is added in neuroglial cytoma U87/LC3, pass through fluorescence
Micro- sem observation, it can clearly be seen that the poly- shape structure of point occurs in cell peripheral.Specifically, GFP-LC3 albumen is being implemented
Obviously changed after the effect of product made from example 3, wherein the structure of the poly- shape of appearance point is such as around U87/LC3 after effect 4h
Shown in Fig. 3 b, and in subsequent 8h to 12h, the structure of this poly- shape of point is always existed, and gradually increases, to the end always
16h, it can be found that eucaryotic cell structure has ruptured, death of neoplastic cells.This change procedure clearly illustrates that embodiment 3 is made
Autophagy phenomenon occurs for the product meeting inducing cell obtained, life of the kelp fermentation liquid that both prepared by embodiment 3 to neuroglial cytoma
It is long that there is good inhibiting effect.
Claims (10)
1. it is a kind of using probiotics fermention kelp preparation malignant tumour medical food raw material method, which is characterized in that including with
Lower step:
(1) kelp is crushed, Kelp Powder is made；
(2) one time fermentation culture medium is added in Kelp Powder made from step (1), be uniformly mixed, then access bacillus bacterium solution
Afterwards, one time fermentation removes bacillus thallus, and kelp first time fermentation liquid is made；
The bacillus is one of bacillus subtilis, bacillus pumilus, bacillus licheniformis, bacillus coagulans
Or two or more combination；
(3) into kelp first time fermentation liquid made from step (2) inoculating lactic acid bacterium or lactic acid bacteria and Bifidobacterium mixing
Second of fermentation liquid of kelp is made in bacterium, secondary fermentation；
The lactic acid bacteria is lactobacillus plantarum, Lactobacillus casei, streptococcus thermophilus, lactobacillus gasseri, lactobacillus acidophilus and curls
The combination of one or more of lactobacillus；
(4) by second of fermentation liquid made from step (3) through being separated by solid-liquid separation, the spray-dried obtained supernatant dry powder of supernatant, precipitating
Through low temperature drying, after crushing, be made precipitating dry powder, mixing supernatant dry powder and precipitating dry powder to get.
2. the method as described in claim 1, which is characterized in that in the step (1), kelp is for fresh kelp or after being soaked
Kelp, it is dry to water content≤5% after desalination；
It is further preferred that the desalination is to be rinsed 2~5 times using pure water；
It is further preferred that the process that is soaked is as follows: dry kelp being immersed in the pure water of 10~20 times of quality, 20~40
Be soaked 2~7h under conditions of DEG C；
It is further preferred that it is described it is dry use drying mode, 45~90 DEG C of drying temperature.
3. the method as described in claim 1, which is characterized in that in the step (1), powder particle diameter is 10~1000 μm；
Preferably, in the step (1), further include the steps that sterilizing after crushing；It is further preferred that sterilizing is gone out using irradiation
Bacterium, in 1000~2,500 1.5~5h of kilorad irradiation sterilization；It is furthermore preferred that the irradiation sterilization time is 3h.
4. the method as described in claim 1, which is characterized in that in the step (2), one time fermentation condition are as follows: in temperature 35
~38 DEG C, ferment under conditions of 180~220rpm of revolving speed 24~48h；
Preferably, in the step (2), one time fermentation media components are as follows, are weight percentage:
1.5~2.5% glucose, 1.0~2.0% peptones, 0.04~0.06% sodium chloride, 0.04~0.06% beef
The water of cream and surplus.
5. the method as described in claim 1, which is characterized in that in the step (2), the additional amount of Kelp Powder is one time fermentation
The 7~12% of culture medium quality；
Preferably, in the step (2), the access amount of the bacillus bacterium solution is the 1% of one time fermentation culture medium quality
~5%, the cell concentration of bacillus bacterium solution is 1.5~7.5 × 1010cfu/mL。
6. the method as described in claim 1, which is characterized in that in the step (2), removal bacillus thallus is using centrifugation
Separation is centrifuged 8~12min under conditions of 7000~10000rpm.
7. the method as described in claim 1, which is characterized in that in the step (3), the access amount of the lactic acid bacteria is kelp
The 4~6% of first time fermentating liquid volume, the cell concentration of lactic acid bacteria are 2.5~9.5 × 1010cfu/mL；
Preferably, in the step (3), secondary fermentation is that 36~72h is left to ferment under conditions of 28~33 DEG C of temperature.
8. the method as described in claim 1, which is characterized in that in the step (4), be separated by solid-liquid separation as 7000~10000r/
It is centrifuged 10~20 minutes under the conditions of min；
Preferably, in the step (4), spray drying condition are as follows: 90 DEG C of inlet temperature, 65 DEG C of outlet temperature, spray air pressure
Power 0.1Mpa, dry air amount are adjusted to 0.5m3/L；Low temperature drying temperature is 45~65 DEG C.
9. the method as described in claim 1, which is characterized in that in the step (4), before solid-liquid separation step, after further including
Ripe step:
Closed standing under the conditions of second of fermentation liquid of kelp is placed in 8~12 DEG C, 15~30d of after-ripening to get.The effect of after-ripening is
The active constituent in fermentation liquid is set to tend towards stability by low temperature ageing；
Preferably, it in the step (4), crushes to pulverize.
10. malignant tumour medical food raw material made from claim 1 the method is in preparation malignant tumour health food or medicine
Application in object.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811103176.4A CN109288042A (en) | 2018-09-20 | 2018-09-20 | A kind of method and application using probiotics fermention kelp preparation malignant tumour medical food raw material |
| BE20195597A BE1026585B1 (en) | 2018-09-20 | 2019-09-10 | PROCESS AND APPLICATION FOR THE PREPARATION OF A MEDICAL FOOD RAW MATERIAL FOR MALIGNANT TUMORS OF FERMENTED VARECH USING PROBIOTICS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811103176.4A CN109288042A (en) | 2018-09-20 | 2018-09-20 | A kind of method and application using probiotics fermention kelp preparation malignant tumour medical food raw material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109288042A true CN109288042A (en) | 2019-02-01 |
Family
ID=65163830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811103176.4A Pending CN109288042A (en) | 2018-09-20 | 2018-09-20 | A kind of method and application using probiotics fermention kelp preparation malignant tumour medical food raw material |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN109288042A (en) |
| BE (1) | BE1026585B1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111034994A (en) * | 2019-11-18 | 2020-04-21 | 福建卫生职业技术学院 | Preparation method of functional fermented laminarin |
| CN114451532A (en) * | 2022-02-21 | 2022-05-10 | 福建农林大学 | Fermented kelp capable of regulating intestinal flora and preparation method thereof |
| CN114891663A (en) * | 2022-04-13 | 2022-08-12 | 山东筱萤生物科技有限公司 | Lactobacillus plantarum LP1406 and isolated culture method |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101074246A (en) * | 2006-09-21 | 2007-11-21 | 寻山集团有限公司 | Production and use for algin oligose |
| CN101444522A (en) * | 2006-09-21 | 2009-06-03 | 寻山集团有限公司 | Application of algin oligosaccharide |
| KR20110106640A (en) * | 2010-03-23 | 2011-09-29 | 부경대학교 산학협력단 | Functional laminaria fermented powder using lactic acid bacteria in fermentation process and the method thereof |
| CN102326797A (en) * | 2011-07-13 | 2012-01-25 | 福建农林大学 | Method for preparing lactic acid fermentation product of kelp |
| CN102586150A (en) * | 2012-03-03 | 2012-07-18 | 浙江大学舟山海洋研究中心 | Bacterial strain capable of generating alginate lyase and fermentation method thereof |
| CN103881952A (en) * | 2014-04-03 | 2014-06-25 | 大连理工大学 | Bacillus amyloliquefaciens and an application thereof as well as method for preparing kelp feed |
| CN104705709A (en) * | 2015-04-07 | 2015-06-17 | 青岛海洋生物医药研究院股份有限公司 | Method for producing algae ferment through double-term fermentation |
| CN106666502A (en) * | 2017-01-15 | 2017-05-17 | 哈尔滨伟平科技开发有限公司 | Processing method of health-care type kelp powder |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006320257A (en) * | 2005-05-19 | 2006-11-30 | Grandhill Osaka:Kk | Seaweed fermented extract, method for producing the extract, and usage of the extract |
| KR101215931B1 (en) | 2011-05-03 | 2012-12-27 | 한국건설생활환경시험연구원 | Overall pressure roller for constructing self adhesive waterproof sheet with skin having protrusion |
| KR20140057838A (en) | 2012-11-05 | 2014-05-14 | 노길형 | Fermented foods process and production method |
| CN103504368A (en) * | 2013-09-18 | 2014-01-15 | 中国科学院天津工业生物技术研究所 | Kelp-flavored food ingredient and preparation method thereof |
| CN103932273B (en) * | 2014-05-09 | 2016-06-08 | 福建农林大学 | One main laminaria Lactobacillus buccal tablet and preparation method thereof |
| CN107114769A (en) * | 2017-06-29 | 2017-09-01 | 张萌 | Marine alga ferment and preparation method thereof |
| CN108653059B (en) * | 2018-06-20 | 2020-10-23 | 齐鲁工业大学 | Method for preparing seaweed fermentation liquor by probiotic fermentation and application of seaweed fermentation liquor in cosmetics |
-
2018
- 2018-09-20 CN CN201811103176.4A patent/CN109288042A/en active Pending
-
2019
- 2019-09-10 BE BE20195597A patent/BE1026585B1/en active IP Right Grant
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101074246A (en) * | 2006-09-21 | 2007-11-21 | 寻山集团有限公司 | Production and use for algin oligose |
| CN101444522A (en) * | 2006-09-21 | 2009-06-03 | 寻山集团有限公司 | Application of algin oligosaccharide |
| KR20110106640A (en) * | 2010-03-23 | 2011-09-29 | 부경대학교 산학협력단 | Functional laminaria fermented powder using lactic acid bacteria in fermentation process and the method thereof |
| CN102326797A (en) * | 2011-07-13 | 2012-01-25 | 福建农林大学 | Method for preparing lactic acid fermentation product of kelp |
| CN102586150A (en) * | 2012-03-03 | 2012-07-18 | 浙江大学舟山海洋研究中心 | Bacterial strain capable of generating alginate lyase and fermentation method thereof |
| CN103881952A (en) * | 2014-04-03 | 2014-06-25 | 大连理工大学 | Bacillus amyloliquefaciens and an application thereof as well as method for preparing kelp feed |
| CN104705709A (en) * | 2015-04-07 | 2015-06-17 | 青岛海洋生物医药研究院股份有限公司 | Method for producing algae ferment through double-term fermentation |
| CN106666502A (en) * | 2017-01-15 | 2017-05-17 | 哈尔滨伟平科技开发有限公司 | Processing method of health-care type kelp powder |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111034994A (en) * | 2019-11-18 | 2020-04-21 | 福建卫生职业技术学院 | Preparation method of functional fermented laminarin |
| CN114451532A (en) * | 2022-02-21 | 2022-05-10 | 福建农林大学 | Fermented kelp capable of regulating intestinal flora and preparation method thereof |
| CN114891663A (en) * | 2022-04-13 | 2022-08-12 | 山东筱萤生物科技有限公司 | Lactobacillus plantarum LP1406 and isolated culture method |
Also Published As
| Publication number | Publication date |
|---|---|
| BE1026585A1 (en) | 2020-03-25 |
| BE1026585B1 (en) | 2020-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pooja | Algae used as medicine and food-a short review | |
| CN111920040B (en) | Peony fermentation product and preparation method thereof | |
| CN105231444A (en) | Meal replacement combined enzyme and preparation method thereof | |
| AU2004276123A1 (en) | Fermentation and culture method, fermented plant extract, fermented plant extract powder and composition containing the fermented plant extract | |
| CN113604395B (en) | Lactobacillus plantarum capable of fermenting dendrobium nobile and improving skin quality by fermentation liquor thereof | |
| CN109288042A (en) | A kind of method and application using probiotics fermention kelp preparation malignant tumour medical food raw material | |
| CN103689550A (en) | Ganoderma lucidum functional food and preparation method thereof | |
| CN101822373A (en) | Golden-fungus gingko functional food, preparation method and use thereof | |
| CN104706567A (en) | Method for extracting pearl fetal sac liquid from pearl fetal sac of mother pearl shellfish and product thereby | |
| CN105768106A (en) | Liver nutrition improving functional food | |
| CN103045490A (en) | Functional red yeast rice prepared from germinated brown rice and method | |
| CN110663803A (en) | Euphausia superba oil polypeptide biological product capable of benefiting spleen and invigorating stomach | |
| CN114032190A (en) | Lactobacillus reuteri capable of fermenting dendrobium and effectively repairing solar dermatitis by fermentation liquor of dendrobium | |
| CN108486002B (en) | Momordica grosvenori endophyte strain capable of producing exopolysaccharides, method for producing exopolysaccharides and application of exopolysaccharides | |
| CN102174414B (en) | Application of new morchella costata M8-13 liquid fermentation substance in development of health-care products and medicaments | |
| TWI729928B (en) | Concentrate of phellinus linteus extract, method of manufacturing the same and use of the same for preparing composition of improving sleep | |
| CN113372461A (en) | Method for extracting selenium polysaccharide with high antioxidant activity from selenium-rich passion fruit peel | |
| KR20130107940A (en) | Method of producing fermented red ginseng | |
| CN116355816A (en) | Microorganism of fermented samara oil seed and blood lipid reducing composition thereof | |
| CN101912423B (en) | Method for manufacturing Monascus products containing probiotics | |
| JP5081485B2 (en) | Anticancer agent and method for producing anticancer agent | |
| Michalak et al. | Functional fermented food and feed from seaweed | |
| CN115634241A (en) | Preparation method of Shandong ganoderma lucidum extract and application of Shandong ganoderma lucidum extract in preparation of hypoglycemic drugs | |
| CN111450122B (en) | Composite microbial inoculum and application thereof in skin repair | |
| CN111588037A (en) | Euphausia superba oil phospholipid oral liquid with high EPA/DPA (eicosapentaenoic acid/docosahexaenoic acid) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Country or region after: China Address after: 250353 University Road, Changqing District, Ji'nan, Shandong Province, No. 3501 Applicant after: Qilu University of Technology (Shandong Academy of Sciences) Address before: 250353 University Road, Changqing District, Ji'nan, Shandong Province, No. 3501 Applicant before: Qilu University of Technology Country or region before: China |